M.E.E. van Kasteren

1.8k citations

24 papers · 947 indexed · h-index 16

Surgery top 10%
Parasitology top 2%
Infectious Diseases top 10%
Epidemiology
Public Health, Environmental and Occupational Health top 10%

Co-authors: Bart Jan Kullberg Inge C. Gyssens Annette S. de Boer Judith Manniën Alewijn Ott Chantal P. Bleeker‐Rovers Marjolijn Wegdam-Blans Nico Nagelkerke
Topics: Surgical site infection prevention (5 papers)Vector-borne infectious diseases (4 papers)Antibiotic Use and Resistance (4 papers)
Cited by: Applied Microbiology and Biotechnology Parasitology Infectious Diseases
Journals: Clinical Infectious Diseases The Journal of Urology Emerging infectious diseases
Partner nations: Netherlands Curacao United Kingdom

In The Last Decade

M.E.E. van Kasteren

24 papers receiving 912 citations

Peers

Countries citing papers authored by M.E.E. van Kasteren

Since Specialization

Citations

This map shows the geographic impact of M.E.E. van Kasteren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.E.E. van Kasteren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.E.E. van Kasteren more than expected).

Fields of papers citing papers by M.E.E. van Kasteren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.E.E. van Kasteren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.E.E. van Kasteren. The network helps show where M.E.E. van Kasteren may publish in the future.

Co-authorship network of co-authors of M.E.E. van Kasteren

This figure shows the co-authorship network connecting the top 25 collaborators of M.E.E. van Kasteren. A scholar is included among the top collaborators of M.E.E. van Kasteren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.E.E. van Kasteren. M.E.E. van Kasteren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dynamics of Low-Level Viremia and Immune Activation after Switching to a Darunavir-Based Regimen 2024 ·Viruses ·(unknown),(unknown),Wouter F.W. Bierman,Reinout van Crevel,Andy I. M. Hoepelman,Mark A. A. Claassen,Heidi Ammerlaan,Berend J. van Welzen,M.E.E. van Kasteren,S.F.L. van Lelyveld,Dorien de Jong,Kiki Tesselaar,Matthijs van Luin,Monique Nijhuis,Annemarie M. J. Wensing,(unknown)	2
2	Immune reconstitution inflammatory syndrome in HIV infected late presenters starting integrase inhibitor containing antiretroviral therapy 2019 ·EClinicalMedicine ·(unknown),Ferdinand W.N.M. Wit,Casper Rokx,Eliane M.S. Leyten,(unknown),Kees Brinkman,Wouter F.W. Bierman,M.E.E. van Kasteren,(unknown),(unknown),(unknown),Andy I. M. Hoepelman,Marc van der Valk,Peter Reiss,Bart Rijnders	22
3	The Value of ¹⁸F-FDG PET/CT in Diagnosis and During Follow-up in 273 Patients with Chronic Q Fever 2017 ·Journal of Nuclear Medicine ·Ilse J.E. Kouijzer,Linda M. Kampschreur,Peter C. Wever,C. Hoekstra,M.E.E. van Kasteren,(unknown),Marrigje H. Nabuurs-Franssen,Marjolijn Wegdam-Blans,Heidi Ammerlaan,Jacqueline Buijs,Lioe‐Fee de Geus‐Oei,Wim J.G. Oyen,Chantal P. Bleeker‐Rovers	23
4	Cutaneous hyperpigmentation induced by doxycycline: a case series. 2015 ·PubMed ·Stephan P. Keijmel,M.E.E. van Kasteren,Willeke A.M. Blokx,(unknown),Michelle M. van Rossum,Chantal P. Bleeker‐Rovers	10
5	A combination of interferon-gamma and interleukin-2 production by Coxiella burnetii-stimulated circulating cells discriminates between chronic Q fever and past Q fever 2013 ·Clinical Microbiology and Infection ·Teske Schoffelen,T. Sprong,Chantal P. Bleeker‐Rovers,Marjolijn Wegdam-Blans,Anne Ammerdorffer,M.J.H. Pronk,(unknown),M.E.E. van Kasteren,Tineke Herremans,H. A. Bijlmer,Mihai G. Netea,J.W.M. van der Meer,Leo A. B. Joosten,Marcel van Deuren	27
6	Combined infection of vertebroplasty and aortic graft after intravesical BCG treatment 2013 ·BMJ Case Reports ·(unknown),(unknown),Wiel C.M. de Lange,M.E.E. van Kasteren	28
7	Report of two in situ reconstructions with a saphenous spiral vein graft of Coxiella burnetii-infected aneurysms of the abdominal aorta 2012 ·Journal of Vascular Surgery ·(unknown),(unknown),M.E.E. van Kasteren,A. G. M. Buiting,Jan M.M. Heyligers,Patrick W. Vriens	18
8	Chronic Q fever: Review of the literature and a proposal of new diagnostic criteria 2011 ·Journal of Infection ·Marjolijn Wegdam-Blans,Linda M. Kampschreur,Corine Delsing,Chantal P. Bleeker‐Rovers,T. Sprong,M.E.E. van Kasteren,Daan W. Notermans,Nicole H. M. Renders,H. A. Bijlmer,P Lestrade,Marion Koopmans,Marrigje H. Nabuurs-Franssen,Jan Jelrik Oosterheert	147
9	Abacavir/Lamivudine/Zidovudine Maintenance After Standard Induction in Antiretroviral Therapy-Naïve Patients: FREE Randomized Trial Interim Results 2010 ·AIDS Patient Care and STDs ·Herman G. Sprenger,(unknown),Paul Mulder,Chris H.H. ten Napel,(unknown),Andy I. M. Hoepelman,(unknown),Peter P. Koopmans,M.E.E. van Kasteren,Bert Bravenboer,Reinier W. ten Kate,P. H. P. Groeneveld,Tjip S. van der Werf,Elisabeth H. Gisolf,Clemens Richter	4
10	Antibiotic Prophylaxis and the Risk of Surgical Site Infections following Total Hip Arthroplasty: Timely Administration Is the Most Important Factor 2007 ·Clinical Infectious Diseases ·M.E.E. van Kasteren,Judith Manniën,Alewijn Ott,Bart Jan Kullberg,Annette S. de Boer,Inge C. Gyssens	189
11	Effect of Optimized Antibiotic Prophylaxis on the Incidence of Surgical Site Infection 2006 ·Infection Control and Hospital Epidemiology ·Judith Manniën,M.E.E. van Kasteren,Nico Nagelkerke,Inge C. Gyssens,Bart Jan Kullberg,J. Wille,Annette S. de Boer	31
12	Quality improvement of surgical prophylaxis in Dutch hospitals: evaluation of a multi-site intervention by time series analysis 2005 ·Journal of Antimicrobial Chemotherapy ·M.E.E. van Kasteren,Judith Manniën,Bart Jan Kullberg,Annette S. de Boer,Nico Nagelkerke,(unknown),J. Wille,Inge C. Gyssens	101
13	Improving the Process of Antibiotic Therapy in Daily Practice 2004 ·Archives of Internal Medicine ·(unknown),M.E.E. van Kasteren,Stephanie Natsch,Bart Jan Kullberg,Yechiel A. Hekster,J.W.M. van der Meer	32
14	Adherence to local hospital guidelines for surgical antimicrobial prophylaxis: a multicentre audit in Dutch hospitals 2003 ·Journal of Antimicrobial Chemotherapy ·M.E.E. van Kasteren	121
15	[Optimizing antibiotics policy in the Netherlands. V. SWAB guidelines for perioperative antibiotic prophylaxis. Foundation Antibiotics Policy Team]. 2000 ·PubMed ·M.E.E. van Kasteren,Inge C. Gyssens,Bart Jan Kullberg,Hajo A. Bruining,E.E. Stobberingh,R. J. A. Goris	27
16	Urinary Tract Infections With Aerococcus Urinae in the South of The Netherlands 1999 ·The Journal of Urology ·(unknown),M.E.E. van Kasteren,L. Sabbe,Martine De Vos,(unknown),A. G. M. Buiting	3
17	[Optimizing of antibiotics policy in the Netherlands. III. SWAB guidelines for antimicrobial therapy in adults hospitalized with bronchitis. Foundation Antibiotics Policy Work Group]. 1998 ·PubMed ·M.E.E. van Kasteren,W. J. A. Wijnands,E.E. Stobberingh,R. Janknegt,J.W.M. van der Meer	3
18	[Optimization of the antibiotics policy in the Netherlands. II. SWAB guidelines for the antimicrobial therapy of pneumonia in patients at home and as nosocomial infections. The Netherlands Antibiotic Policy Foundation]. 1998 ·PubMed ·M.E.E. van Kasteren,W. J. A. Wijnands,E.E. Stobberingh,R. Janknegt,J.W.M. van der Meer	19
19	[Optimizing antibiotics use policy in the Netherlands. I. The Netherlands Antibiotics Policy Foundation (SWAB)]. 1998 ·PubMed ·M.E.E. van Kasteren,W. J. A. Wijnands,E.E. Stobberingh,(unknown),(unknown),(unknown)	2
20	Urinary tract infections withAerococcus urinae in the South of the Netherlands 1997 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown),M.E.E. van Kasteren,L. Sabbe,Martine De Vos,(unknown),A. G. M. Buiting	52

About M.E.E. van Kasteren

M.E.E. van Kasteren is a scholar working on Applied Microbiology and Biotechnology, Virology and Parasitology, having authored 24 papers that have together received 947 indexed citations. Recurring topics across this work include Surgical site infection prevention (5 papers), Vector-borne infectious diseases (4 papers) and Antibiotic Use and Resistance (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (106 citations), Parasitology (249 citations) and Infectious Diseases (224 citations). M.E.E. van Kasteren has collaborated with scholars based in Netherlands, Curacao and United Kingdom. Frequent co-authors include Bart Jan Kullberg, Inge C. Gyssens, Annette S. de Boer, Judith Manniën, Alewijn Ott, Chantal P. Bleeker‐Rovers, Marjolijn Wegdam-Blans, Nico Nagelkerke, H. A. Bijlmer and J. Wille. Their work appears in journals such as Clinical Infectious Diseases, The Journal of Urology and Emerging infectious diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact